Ghulam Rhahim Awab
Senior researcher
Since graduation as MD holder in 1995, I am a public health and medicine certified employee in governmental, UN & non governmental organization, currently Medical faculty member of Nangarhar University as well as MORU research collaborator since 2007.
My expertise includes management, teaching, mentoring, and research in the filed of Public health & preventive medicine, Social and behavioral science, Tropical Medicine & Global Health, Infectious Disease & Immunology, Medical and research ethics, project design/planning, monitoring/evaluation and social mobilization.
I enjoy new ideas and feasible solutions to relevant problems. I am described as honest, committed, driven, and resourceful who maintains a positive, proactive attitude when faced with adversity.
My diverse interests include the epidemiology, pathophysiology and management of malaria, typhoid, HIV, Diarrhea, dengue fever, tuberculosis, anemia, malnutrition and poverty. My particular interests at present include the malaria control/elimination, the prevention of antimalarial drug resistance using traditional and artemisinin-based combination treatment, the risk of relapsing vivax malaria, radical cure and G6PD deficiency’s prevalence, types, effects and safety.
With MORU collaborators I conduct clinical research to help improve global, regional and national health and to build capacity for this in medical faculties and in local settings. My research aims to provide global and local organizations with key data to help make evidence-based decisions for patients, curricula & health policy.
Currently, I’m seeking opportunities to strengthen and promote local capacity, improve data use, technologies for evidence-based decisions to benefit human health. My specific interests include data analytics, datashare biotechnology, networking and medicine quality.
Recent publications
-
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183
-
Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study.
Journal article
Florimond C. et al, (2024), The Lancet. Infectious diseases, 24, 161 - 171
-
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Journal article
Rajasekhar M. et al, (2024), The Lancet Infectious Diseases, 24, 184 - 195
-
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Journal article
Mehdipour P. et al, (2023), Malaria Journal, 22
-
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Journal article
Taylor WRJ. et al, (2023), PLOS Neglected Tropical Diseases, 17, e0011522 - e0011522